Laboratory scale production of injectable liposomes by using cell disruptor to avoid the probe sonication process
Authors:
- 2 August 2014
- journal article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 45 (1) , 73-78
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivativeInternational Journal of Pharmaceutics, 2012
- Dispersion and stability of bare hematite nanoparticles: Effect of dispersion tools, nanoparticle concentration, humic acid and ionic strengthScience of The Total Environment, 2012
- Preparation andin vitroevaluation of anti-VCAM-1-Fab′-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxibJournal of Microencapsulation, 2011
- Enhanced efficacy of TD53, a novel algicidal agent, against the harmful algae via the liposomal delivery systemInternational Journal of Pharmaceutics, 2011
- Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasoneInternational Journal of Pharmaceutics, 2010
- The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: From a coarse to a fine dispersionInternational Journal of Pharmaceutics, 2009
- Effect of coupling of albumin onto surface of PEG liposome on its in vivo dispositionInternational Journal of Pharmaceutics, 2007
- A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid–liposome interactions for liposomes prepared by thin film and proliposome methodsInternational Journal of Pharmaceutics, 2006
- Drug–target residence time and its implications for lead optimizationNature Reviews Drug Discovery, 2006